ATE427736T1 - Pharmazeutische zubereitungen zur parenteralen verabreichung enthaltend epothilon - Google Patents
Pharmazeutische zubereitungen zur parenteralen verabreichung enthaltend epothilonInfo
- Publication number
- ATE427736T1 ATE427736T1 AT07102856T AT07102856T ATE427736T1 AT E427736 T1 ATE427736 T1 AT E427736T1 AT 07102856 T AT07102856 T AT 07102856T AT 07102856 T AT07102856 T AT 07102856T AT E427736 T1 ATE427736 T1 AT E427736T1
- Authority
- AT
- Austria
- Prior art keywords
- parenteral administration
- pharmaceutical preparations
- administration containing
- epothilone
- containing epothilone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802451.6A GB9802451D0 (en) | 1998-02-05 | 1998-02-05 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427736T1 true ATE427736T1 (de) | 2009-04-15 |
Family
ID=10826504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07102856T ATE427736T1 (de) | 1998-02-05 | 1999-02-03 | Pharmazeutische zubereitungen zur parenteralen verabreichung enthaltend epothilon |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1800664B8 (de) |
AT (1) | ATE427736T1 (de) |
CY (1) | CY1109190T1 (de) |
DE (1) | DE69940708D1 (de) |
DK (1) | DK1800664T3 (de) |
ES (1) | ES2324376T3 (de) |
GB (1) | GB9802451D0 (de) |
PT (1) | PT1800664E (de) |
ZA (1) | ZA99874B (de) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4138042C2 (de) * | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
ES2178093T5 (es) * | 1995-11-17 | 2009-02-16 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Derivados de epotilon y su preparacion. |
HU226646B1 (en) * | 1996-03-12 | 2009-05-28 | Pg Txl Company | Water soluble pharmaceutical compositions containing taxane derivatives |
US6441186B1 (en) * | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
MY125921A (en) * | 1998-02-05 | 2006-08-30 | Novartis Ag | Compositions containing organic compounds |
-
1998
- 1998-02-05 GB GBGB9802451.6A patent/GB9802451D0/en not_active Ceased
-
1999
- 1999-02-03 PT PT07102856T patent/PT1800664E/pt unknown
- 1999-02-03 DE DE69940708T patent/DE69940708D1/de not_active Expired - Lifetime
- 1999-02-03 EP EP07102856A patent/EP1800664B8/de not_active Revoked
- 1999-02-03 ES ES07102856T patent/ES2324376T3/es not_active Expired - Lifetime
- 1999-02-03 AT AT07102856T patent/ATE427736T1/de active
- 1999-02-03 DK DK07102856T patent/DK1800664T3/da active
- 1999-02-04 ZA ZA9900874A patent/ZA99874B/xx unknown
-
2009
- 2009-06-30 CY CY20091100693T patent/CY1109190T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69940708D1 (de) | 2009-05-20 |
PT1800664E (pt) | 2009-07-10 |
GB9802451D0 (en) | 1998-04-01 |
EP1800664A1 (de) | 2007-06-27 |
ES2324376T3 (es) | 2009-08-05 |
EP1800664B8 (de) | 2010-12-15 |
EP1800664B1 (de) | 2009-04-08 |
ZA99874B (en) | 1999-08-05 |
DK1800664T3 (da) | 2009-07-20 |
CY1109190T1 (el) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002299T2 (tr) | Epotilon kompozisyonları. | |
DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
NO980081L (no) | Farmasöytiske preparater | |
ATE277630T1 (de) | Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
AR019855A1 (es) | Uso de conjugados de peg-ifn-alfa y ribavirina para la fabricacion de un medicamento para el tratamiento de hepatitis c cronica | |
NO20015584D0 (no) | Lantidsvarende insulintrofiske peptider | |
HUP0101293A2 (hu) | AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
DE69923336D1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
DE50003454D1 (de) | Proteinenthaltende pharmazeutische zubereitung | |
NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
AU3638399A (en) | Methods for preparation and use of tree injection nutrients and/or medicinal materials | |
WO2000003724A1 (fr) | Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif | |
DE60004204D1 (de) | Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung | |
MX9805939A (es) | Formas solidas de administracion, de liberacion instantanea y procesos para su produccion. | |
DE69940708D1 (de) | Pharmazeutische Zubereitungen zur parenteralen Verabreichung enthaltend Epothilon | |
ATE208627T1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen | |
MY106672A (en) | Dichloroaniline compound. | |
WO2000017366A3 (en) | Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug | |
ECSP992852A (es) | Compuestos organicos | |
AU6553900A (en) | Water-soluble cephalomannine esters with poly-amino-acid or the salts thereof, pharmaceutical compositions containing them and their use in medicine | |
FR2652266B1 (fr) | Vaccin protecteur contre l'hemophilose porcine. | |
AU3278400A (en) | New use of taxoid derivatives | |
ECSP972242A (es) | Producto farmaceutico cristalino |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1800664 Country of ref document: EP |